Paul Goodwin is a member of the Cabot investment team, and chief analyst of Cabot Emerging Markets Investor. He is also a news writer for Cabot’s free e-newsletter, Wall Street’s Best Daily.
Under Paul’s stewardship, the Cabot Emerging Markets Investor was ranked by Hulbert Financial Digest as one of the top-performing newsletter for the past five years every month from March 2009 through July 2011. Hulbert named Cabot Emerging Markets Investor the top-performing newsletter for two years in a row: in 2006 with a 76% gain and 2007 with a 74.1% gain. The advisory was also named Investment Letter of the Year for 2007 by Peter Brimelow of MarketWatch and Best Financial Advisory Newsletter in 2008 by the Specialized Information Publishers Foundation. The Cabot Emerging Markets Investor portfolio was a top performer again in 2013 with a 50.1% return according to Hulbert.
A researcher and writer for over 30 years, Paul brings a lifetime of inquiry to the task of figuring out whether stocks and markets are likely to go up or down. Prior to joining Cabot, Paul was a senior financial writer for Putnam Investments’ international and institutional communications, professor at the University of New Hampshire, and a Chinese linguist for the U.S. Army Security Agency.
Paul regularly delivers the Cabot weekly market update in video on the Cabot website. He has offered his outlook for emerging markets equities in numerous appearances on financial news organizations and quoted in financial publications including Bloomberg TV, CNBC, MSN Money, Dow Jones MarketWatch, WallStreetReporter.com, SeekingAlpha.com, AOL Money & Finance and Reuters.
The iShares MSCI EM ETF (EEM) has been under quite a bit of selling pressure over the past four days, dropping it from a close above its 25-day moving average last Wednesday to within shouting distance of its 200-day moving average today.
Read More
In this week's video, Paul Goodwin, chief analyst of Cabot Emerging Markets Investor looks at stock markets that don't really have a definite direction. The major indexes have made up about half of their losses, but haven't stormed back above their 25- 50-day...
Read More
The iShares EM Fund (EEM) has firmed up over the last few days, but has yet to actually kick out to the upside. So, while it’s still in the vicinity of its moving averages, we still have a caution signal in force.
Read More
Buy and hold is what we've been taught as long-term growth investors. But to make money on more volatile stocks, a buy-and-sell approach is essential.
Read More
There are three reasons not to let the market's momentum make your investing decisions for you, especially not about how you manage stocks you already own.
Read More
People always ask us how we manage to find the market's leading growth stocks. Here are five characteristics we screen for.
Read More
In this week's video, Paul Goodwin, chief analyst of Cabot Emerging Markets Investor looks at the wretched state of the market as the major indexes look to be retesting February lows with the S&P perilously close to its 200-day moving average and only one-day...
Read More
The shares of this tech company were recently upgraded to ‘Positive’ by Susquehanna, who cited the company’s ‘hypergrowth’ and raised its price target to $41.
Read More
Our Emerging Markets Timer has turned negative, but its action of the past two months looks more like a trading range than a downtrend. Overall we continue to take things on a stock-by-stock basis; we have several stocks that are teetering on the of...
Read More
Stressing over what to do with your falling stocks during this market correction? Here is a simple solution that has worked for our readers.
Read More
The best growth stocks typically share a few common characteristics. Here are three traits I look for - though one trait is especially important.
Read More
In this week's video, Paul Goodwin, chief analyst of Cabot Emerging Markets Investor talks about the general good health of the market, but especially about how the Nasdaq Index is outperforming the S&P 500 and both are stronger than the Dow. This means growth...
Read More
The iShares EM Fund (EEM) bounced strongly in early March, which returns the Emerging Markets Timer to a positive reading. Granted, it's not the strongest signal we've ever seen, but it counts. Quarterly reports are winding up, and we’ll take the Timer’s advice return...
Read More
One of our stocks reported this morning and results came in just shy of expectations. The bottom line is that the stock is selling off hard and is back down to its 200-day line, and in the zone of support that’s held for last...
Read More
Two of our stocks reported their latest quarterly results yesterday and both disappointed; one is now rated Sell.
Read More
Any stock that can deliver a ten-bagger in less than two years is bound for the Hall of Fame, and that’s exactly what Weibo stock did for my subscribers.
Read More
The Chinese biotech market is heating up and the stock of this company is rapidly gaining momentum.
Read More
Following what seemed to be a perfectly successful quarterly report on Monday evening, YY opened up today but then plowed steadily lower all morning. The stock found support at 117, and rebounded slightly finishing the day near 120.
Read More
In this week's video, Paul Goodwin, chief analyst of Cabot Emerging Markets Investor surveys the damage caused by overly honest remarks from the new Fed chief and the rash remarks about tariffs from another relative Washington newcomer. The negative action over the past days...
Read More
he iShares EM Fund (EEM) has dropped decisively below its 25- and 50-day moving averages, which returns the Emerging Markets Timer to a negative reading. We take the Timer’s advice seriously, so we are shifting a couple of stocks to Hold ratings, but the...
Read More
